Diamedica Therapeutics(DMAC)
$8.02-0.57 (-6.64%)
DMAC
Diamedica Therapeutics earnings date
$8.02
At close:-0.57 (-6.64%)
Want to see DMAC full AI Analyst Report?
Diamedica Therapeutics (DMAC) Q2 2024 Earnings Report
573 Followers
DMAC Q2 2024 EPS Results
- Actual EPS
- -$0.13
- Consensus EPS
- -$0.16
- Beat/Miss
- Beat by +$0.03
- One Year Ago EPS
- -$0.16
DMAC Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/07/2024
- Time
- After Close
- Conference Call
- Wednesday, August 7, 2024
DMAC Upcoming Earnings
Diamedica Therapeutics's next earnings date is estimated for March 23, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DMAC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 23, 2027 | 2026 (Q4) | -0.24- | -0.17 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.21-0.21 | -0.17 | -23.53% (-0.04) | |
| Aug 10, 2026 | 2026 (Q2) | -0.20-0.19 | -0.18 | -5.56% (-0.01) | |
| May 06, 2026 | 2026 (Q1) | -0.19-0.19 | -0.18 | -5.56% (-0.01) | |
| Mar 30, 2026 | 2025 (Q4) | -0.18-0.17 | -0.18 | 5.56% (+0.01) | |
| Nov 12, 2025 | 2025 (Q3) | -0.16-0.17 | -0.15 | -13.33% (-0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.19-0.18 | -0.13 | -38.46% (-0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.18-0.18 | -0.14 | -28.57% (-0.04) | |
| Mar 17, 2025 | 2024 (Q4) | -0.17-0.18 | -0.12 | -50.00% (-0.06) | |
| Nov 13, 2024 | 2024 (Q3) | -0.15-0.15 | -0.12 | -25.00% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

